NO941377L - Cellesykluskontrollerende preparater og fremgangsmåte for anvendelse av slike - Google Patents

Cellesykluskontrollerende preparater og fremgangsmåte for anvendelse av slike

Info

Publication number
NO941377L
NO941377L NO941377A NO941377A NO941377L NO 941377 L NO941377 L NO 941377L NO 941377 A NO941377 A NO 941377A NO 941377 A NO941377 A NO 941377A NO 941377 L NO941377 L NO 941377L
Authority
NO
Norway
Prior art keywords
cell cycle
cell
methods
protein
cycle controlling
Prior art date
Application number
NO941377A
Other languages
English (en)
Other versions
NO941377D0 (no
NO315895B1 (no
Inventor
Wen-Hwa Lee
Eva Y H P Lee
David W Goodrich
Nang-Ping Wang
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO941377D0 publication Critical patent/NO941377D0/no
Publication of NO941377L publication Critical patent/NO941377L/no
Publication of NO315895B1 publication Critical patent/NO315895B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19941377A 1991-10-17 1994-04-15 Farmasöytisk preparat for kontroll av cellesyklusutvikling, fremstilling avdette for regulering av cellesyklusutvikling i en celle sommangler et funksjonelt retinoblastomtumorsuppressorprotein, samt fremgangsmåte forkontroll av cellesyklusutv NO315895B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77851091A 1991-10-17 1991-10-17
PCT/US1992/008918 WO1993008267A1 (en) 1991-10-17 1992-10-16 Cell cycle controlling compositions and methods of using same

Publications (3)

Publication Number Publication Date
NO941377D0 NO941377D0 (no) 1994-04-15
NO941377L true NO941377L (no) 1994-06-10
NO315895B1 NO315895B1 (no) 2003-11-10

Family

ID=25113590

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19941377A NO315895B1 (no) 1991-10-17 1994-04-15 Farmasöytisk preparat for kontroll av cellesyklusutvikling, fremstilling avdette for regulering av cellesyklusutvikling i en celle sommangler et funksjonelt retinoblastomtumorsuppressorprotein, samt fremgangsmåte forkontroll av cellesyklusutv

Country Status (11)

Country Link
EP (1) EP0610420B1 (no)
JP (2) JP3450006B2 (no)
KR (1) KR100279797B1 (no)
AT (1) ATE191928T1 (no)
AU (1) AU679431B2 (no)
CA (1) CA2120353C (no)
DE (1) DE69230943T2 (no)
ES (1) ES2148181T3 (no)
NO (1) NO315895B1 (no)
TW (1) TW346397B (no)
WO (1) WO1993008267A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666312A1 (en) * 1994-02-08 1995-08-09 Wolfgang A. Renner Process for the improvement of mammalian cell growth

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341576C (en) * 1986-08-11 2008-07-08 Thaddeus P. Dryja Diagnosis of retinoblastoma
JP3163090B2 (ja) * 1988-01-21 2001-05-08 マサチューセッツ アイ アンド イヤー インファーマリー 網膜芽腫診断剤
ZA909755B (en) * 1989-12-07 1991-09-25 Res Dev Foundation Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

Also Published As

Publication number Publication date
AU3054692A (en) 1993-05-21
TW346397B (en) 1998-12-01
WO1993008267A1 (en) 1993-04-29
KR100279797B1 (ko) 2001-04-02
EP0610420B1 (en) 2000-04-19
JP2003277290A (ja) 2003-10-02
AU679431B2 (en) 1997-07-03
NO941377D0 (no) 1994-04-15
JPH07504805A (ja) 1995-06-01
DE69230943T2 (de) 2000-11-30
EP0610420A1 (en) 1994-08-17
ES2148181T3 (es) 2000-10-16
NO315895B1 (no) 2003-11-10
CA2120353A1 (en) 1993-04-29
CA2120353C (en) 2008-04-29
DE69230943D1 (de) 2000-05-25
ATE191928T1 (de) 2000-05-15
JP3450006B2 (ja) 2003-09-22

Similar Documents

Publication Publication Date Title
ATE43635T1 (de) Verfahren zur herstellung von interferon und expressionsvektoren dafuer.
BR9608114A (pt) Vacinas de pertussis a celular e processos para preparação das mesmas
DK322188D0 (da) Fremgangsmaade til fremstilling af protein
ATE159429T1 (de) Methode zum überbringen von agenzien an zielzellen
DK59691D0 (da) Fremgangsmaade til fremstilling af liposomer med forbedret stabilitet under toerring
DK106288A (da) Osteoinduktive praeparater
AU4533589A (en) Skin test and test kit for aids
BR9206433A (pt) Formulação e processo para tratar ferimentos.
DK512686A (da) Thrombinpraeparater, deres fremstilling og anvendelse
ES2018923A6 (es) Un metodo para producir microparticulas dispersables en agua de proteina insoluble en agua.
DE3582272D1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
ATE219683T1 (de) Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
DK0419878T3 (da) Nye aprotinin-varianter og genteknologisk fremgangsmåde til mikrobiel fremstilling af disse varianter i homogent processeret form
AU2861389A (en) Disubstituted pyridines
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
EP0369816A3 (en) Monoclonal antibodies specific for human polymorphic epithelial mucin
NO941377D0 (no) Cellesykluskontrollerende preparater og fremgangsmåte for anvendelse av slike
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
EP0145486A3 (en) Microbiological process
FI891020A (fi) Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi
AU4504793A (en) Method for preparing membrane proteins and preserving their oligomeric structures under denaturing conditions, and uses of said proteins in diagnostics and vaccination
DE3880122D1 (de) Verfahren zur solubilisierung von unloeslichem protein.
NO940406L (no) Preparat og fremgangsmåte for behandling av sårskader